We use essential cookies (authentication, your saved goals/stack) by default. With your permission we’ll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
D-Mannose
Binds E. coli in urine to prevent bladder wall adhesion. Promising for recurrent UTI prevention, but the evidence is mixed — the largest, best-quality recent trial and meta-analysis found no significant benefit.
What the evidence says
D-Mannose helped in about half (2/3) of the studies that measured an effect — promising, but not unanimous.
Most evidence is from high-quality meta-analyses and randomised trials published 2014–2026 with a typical study size of 95 participants.
Based on 43 studies · 3 meta-analyses · 18 RCTs · 14,033 total participants
Confidence
High confidenceWhat the studies found
By outcome
Earlier RCTs and meta-analyses suggested D-mannose prevents recurrent UTIs via a sound anti-adhesion mechanism, but the largest 2024 RCT and a 2025 meta-analysis found no significant benefit — leaving the evidence mixed.
6 trials ongoing or recruiting · 34 completed on ClinicalTrials.gov
9 of the completed trials have posted results
Registered trials show research momentum for D-Mannose, not proof of effect — a registration is a plan, and posted results are sponsor-reported, not peer-reviewed. They are never counted toward the evidence rating above.
Browse these trials on ClinicalTrials.govClinicalTrials.gov · as of Oct 2026
D-Mannose is a naturally occurring sugar related to glucose that's poorly absorbed and largely excreted in urine. This property gives it a plausible mechanism for UTI prevention — it binds to E. coli bacteria (which cause 80-90% of UTIs) and prevents them from adhering to the bladder wall.
Early smaller RCTs and meta-analyses suggested a protective effect for recurrent UTIs in women, but the largest and best-conducted recent evidence is null: a 2024 JAMA Internal Medicine RCT (~600 women in primary care) found no reduction in suspected UTIs and concluded D-mannose should not be recommended for prophylaxis, and a 2025 meta-analysis of RCTs found no significant reduction versus control.
A 2022 Cochrane review found little to no high-quality evidence either way. The honest verdict is mixed: a well-tolerated option with a sound mechanism but inconsistent clinical results.
Binds to E. coli fimbriae, preventing attachment
Bacteria-mannose complexes are flushed out with urination
How D-Mannose works — from molecular targets to health outcomes. Click an edge to see supporting research.This visualization is in beta — pathways are being refined and expanded.
Likely safe
Diabetes: discuss D-mannose use and any monitoring needs with the clinician managing your diabetes.
May theoretically affect blood sugar; most is excreted unabsorbed
Tip: Reduce dose
Tip: Normal osmotic effect at high doses
D-Mannose has an evidence score of 5/10 — moderate evidence based on 42 indexed studies, including 3 meta-analyses. Binds E. coli in urine to prevent bladder wall adhesion. Promising for recurrent UTI prevention, but the evidence is mixed — the largest, best-quality recent trial and meta-analysis found no significant benefit. Representative study: PMID 39095666.
The commonly studied dose of D-Mannose is 2g daily for prevention; 1.5-2g every 2-3 hours for acute symptoms. The cited trials used 2 g a day for prevention, none states a dose for acute symptoms. Individual needs vary — start at the lower end of the range and adjust based on how you respond.
The best time to take D-Mannose is between meals. It can be taken on an empty stomach. D-mannose is a simple sugar that is minimally metabolized and is largely excreted intact via the kidneys into the urine.
D-Mannose is generally well-tolerated and considered safe for most healthy adults at recommended doses. Reported side effects are uncommon and include bloating/loose stools, diarrhea (high doses).
Lactoferrin
Too few graded studiesA multifunctional iron-binding glycoprotein from milk with broad antimicrobial, anti-inflammatory, and immune-modulating properties.
Beta-Glucans
Likely helpsPolysaccharides from yeast, mushrooms, or oats that train innate immune cells to respond faster to infections and pathogens.
CoQ10
Likely helpsA lipid-soluble antioxidant central to mitochondrial energy production, with the strongest trial support for fertility/IVF outcomes and heart failure.
Red Yeast Rice
Likely helpsFermented rice containing natural statins that effectively lower LDL cholesterol — the original statin.
Explore: Best supplements for Vitality & Longevity
Reviewed by Dr. Baher Al Hakim · Last reviewed May 2026 · evidence from 43 studies · how we score · editorial policy
This information is for educational purposes only. It is not a substitute for professional medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any supplement or medication.
Tap node to isolate • Pinch to zoom • Tap edge for research